Tuesday, 28 September 2021

 

 

LATEST NEWS Union MoRTH Nitin Gadkari, Lt Governor lay foundation for four National Highway Projects worth Rs 3612 Cr Two-day visit of Union Minister for I&B to Ganderbal concludes Rs 200 Cr. allotted for Development of sports infrastructure on modern pattern in U.T of J&K : Anurag Thakur Ramdas Athawale takes stock of implementation of social welfare schemes in Jammu Union Minister of State Tribal Affairs Renuka Singh visits District Kulgam Union MoS Road Transport and Highways, Civil Aviation Dr. V. K. Singh visits Anantnag Union MoS, Tribal Affairs Renuka Singh interacts with DDC, BDC members, other PRI representatives at Kulgam Union Minister of State for Finance inaugurates various development projects in Jammu Union MoS Jal Shakti, Tribal Affairs, Bishweswar Tudu concludes visit to Kishtwar Lt Governor visits “The Paradise Fest” organized to celebrate World Tourism Week Charanjit Singh Channi Asks Administrative Secretaries To Prepare 100 Days Roadmap To Ensure Holistic Development Of State Charanjit Singh Channi Calls Emergency Meeting On Farmers' Issues In Wake Of 'Bharat Bandh' Call Given By Samyukt Kisan Morcha Charanjit Singh Channi Curtails Security Of VVIPs SSP Pulwama Gulam Jeelani Wani, assume charge, held introductory meeting with Visits various posts of district police Pulwama Parliamentarian Delegation arriving to interact with common people in Kashmir Assam's highest civilian award for national integration to be conferred by V-P Naidu RSS statement on Amazon irrelevant : Randeep Singh Surjewala India-US enhanced ties to boost research, health management : Bharati Pravin Pawar Shafali Verma and Radha Yadav sign up for Sydney Sixers in WBBL England cricketer Moeen Ali retires from Test cricket Don't see that aggressiveness in this Mumbai Indians side : Zaheer Khan

 

Antibodies drop 50% in 3 months of Pfizer, AstraZeneca jabs: Study

Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Oxygen supply, Liquid Medical Oxygen, Oximeter

Web Admin

Web Admin

5 Dariya News

London , 27 Jul 2021

Total antibody levels produced by both Pfizer and AstraZeneca appear to start declining from as early as six weeks after two vaccine doses and can reduce by more than 50 per cent over 10 weeks, according to a new study stressing the need for booster doses.The study, led by researchers of the University College London, showed that the waning effect of the vaccine doses were consistent across all groups of people regardless of age, chronic illnesses or sex.Published as a research letter in The Lancet, the study included data from over 600 people and showed antibody levels are substantially higher following two doses of the Pfizer vaccine than after two doses of the AstraZeneca jab.They are also much higher in those with prior SARS-CoV-2 infection.The researchers highlighted that although the clinical implications of waning antibody levels are not yet clear, some decline was expected and current research shows that vaccines remain effective against severe disease.For Pfizer, antibody levels reduced from a median of 7506 U/mL at 21-41 days, to 3320 U/mL at 70 or more days. For AstraZeneca, antibody levels reduced from a median of 1201 U/mL at 0-20 days to 190 U/mL (67-644) at 70 or more days."The levels of antibody following both doses of either the AstraZeneca or Pfizer vaccine were initially very high, which is likely to be an important part of why they are so protective against severe Covid-19," said Maddie Shrotri from the UCL Institute of Health Informatics.

"However, we found these levels dropped substantially over the course of two to three months. If they carry on dropping at this rate, we are concerned that the protective effects of the vaccines may also begin to wear off, particularly against new variants; but we cannot yet predict how soon that might happen," she added.The findings support recommendations from the UK Joint Committee on Vaccination and Immunization (JCVI) that adults who are clinically vulnerable, those aged 70 years or over, and all residents of care homes for older adults should be prioritised for booster doses."In addition, those who were vaccinated with the AstraZeneca vaccine, including most care home residents, are likely to have much lower antibody levels than those vaccinated with the Pfizer vaccine, so this may also need to be considered when deciding who should be prioritised when boosters are rolled out," said Professor Rob Aldridge from the UCL Institute of Health Informatics.However, the study included only a small sample size and different people will have different levels of immunity depending on the virus neutralizing ability of their antibodies as well as their T-cell responses.Thus, additional research is important to establish if there is an antibody level threshold needed for protection against severe disease, the researchers noted.

 

Tags: Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Oxygen supply , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD